Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Martin Shkreli

Martin Shkreli Blasts Trump's Move To Buy Shares Of Quantum Computing Companies For the US Government, Suggests The President Should Do This Instead

Investor Martin Shkreli, popularly known as “Pharma Bro,” is criticizing President Donald Trump’s latest decision to acquire equity stakes in quantum computing stocks.

Benzinga

What's Driving Beyond Meat's 19% Pre-Market Drop? (CORRECTED)

Editor’s note: The story has been corrected to reflect Beyond Meat’s correct trading volume on Wednesday and the pre-market movement on Thursday.

Benzinga

Latest Beyond Meat Short-Seller? Martin Shkreli, Of Course

Beyond Meat, Inc. (NASDAQ:BYND) shares ripped higher on Wednesday as traders discussed a possible "short-squeeze" due to outsized short interest in the stock.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Quantum Stock Tracker: Early Rally Fades, Rigetti And D-Wave Still Up On The Week

Quantum stocks pulled back on Thursday and Friday after a strong rally earlier in the week. Here's a look at what drove the early rally and the pull-back that followed.

Benzinga

Quantum Stock Rally Leaves Shkreli's Short 'Pretty F***n' Far From Okay'

Martin Shkreli, known for his outspoken views in finance, has been shorting quantum computing stocks IonQ, Inc. (NYSE:IONQ), D-Wave Quantum, Inc. (NYSE:QBTS), Rigetti Computing, Inc. (NASDAQ:RGTI), and Quantum Computing Inc. (NASDAQ:QUBT), regularly mocking what he sees as overvaluation and questionable business models.

Benzinga

'Pharma Bro' Martin Shkreli Says Tesla Haters Suffer From 'Common' Delusions: 'TSLAQ' Community Will Require 'Lifelong Institutionalization'

Investor Martin Shkreli, popularly referred to as the “Pharma Bro,” has once again criticized investors who are bearish on Tesla Inc. (NASDAQ:TSLA), even comparing their bets against the electric vehicle giant to several common psychiatric delusions.

Benzinga

Elon Musk 'Won, It's Over': 'Pharma Bro' Defends Tesla Against Short Sellers

Known in the past as the "Pharma Bro" for his ties to the pharmaceutical industry, Martin Shkreli is known these days for shorting individual stocks or entire sectors, like a recent bet against public quantum computing companies.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Diddy wants to serve his time at same low-security prison that housed ‘Pharma Bro’ and influencer ‘Hushpuppi’

The rapper requested to serve time at Fort Dix ‘to address drug abuse issues and to maximize family visitation and rehabilitative efforts’

The Independent UK

Sean 'Diddy' Combs' lawyers want him sent to a New Jersey federal prison that offers drug treatment

Sean “Diddy” Combs’ lawyers want the hip-hop mogul sent to a low-security federal prison in New Jersey to serve his four-year, two-month prison sentence

The Independent UK

Martin Shkreli Defends Nvidia-OpenAI Deal: It's A 'Lot More Efficient' This Way — 'Pharma Bro' Cites Growing 'Non-Party Demand'

Investor Martin Shkreli came out in support of the $100 billion investment pledge made by chipmaker NVIDIA Corp. (NASDAQ: NVDA) to ChatGPT-parent OpenAI last week, while arguing that critics are missing the point of how value is created and measured in such partnerships.

Benzinga

'Pharma Bro' Martin Shkreli Mocks IONQ CEO's Nvidia-Sized Ambition: 'Craziest Statement From A CEO I Have Ever Heard'

Investor Martin Shkreli, popularly known as “Pharma Bro,” is once again criticizing quantum computing company, IONQ Inc. (NYSE: IONQ), for comments made by its CEO, Peter Chapman.

Benzinga

Opendoor Is 'Total Garbage,' This Hedge Fund Manager Says: 'The Business Model Does Not Work'

Hedge fund manager George Noble criticized iBuying platform Opendoor Technologies Inc. (NASDAQ:OPEN), which has seen a monumental 1,776% rally since hitting an all-time low in late June.

Benzinga

Martin Shkreli Amplifies Critique Calling D-Wave's Quantum Tech 'Dead-End:' It Would Take Until 2054 To Match Current Classical Solvers

A critique of D-Wave Quantum Inc. (NYSE:QBTS), amplified by ‘Pharma Bro’ Martin Shkreli, is challenging the company’s viability, alleging its technology is a potential “dead-end.”

Benzinga

5 Stocks That Dominated Investor Buzz This Week — How OPEN, NVDA, TSLA And Others Performed

Retail investors buzzed about five stocks this week, from Sept. 15 to 19, on platforms like X and Reddit’s r/WallStreetBets, amid market AI enthusiasm and the Federal Reserve rate cuts.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

'Pharma Bro' Martin Shkreli Tells Critics 'Do Not Make Fun of Me' As Opendoor Short Sours Amid Rate-Cut Rally: 'That Is Inappropriate'

Investor Martin Shkreli, popularly known as “Pharma Bro,” pushed back against criticism on this recent short position on iBuying platform Opendoor Technologies Inc. (NASDAQ:OPEN), which is rallying amid the Federal Reserve’s rate cuts on Wednesday.

Benzinga

Jim Cramer Pushes For 'Gone Meme' Stock List As Opendoor Surges, Suggests IonQ's Meme Moment Is Over

CNBC's Jim Cramer called for the creation of a "gone meme list" in a post on the social media platform X on Wednesday, suggesting a need to track companies whose speculative trading frenzy has concluded.

Benzinga

Pharma Bro Martin Shkreli Confirms Shorting Opendoor, Plans Public Due Diligence Campaign Into The Firm: 'I Shorted $OPEN'

Martin Shkreli, also popularly known as ‘Pharma Bro,’ announced late Tuesday that he has taken a short position against iBuying real estate company Opendoor Technologies Inc. (NASDAQ:OPEN).

Benzinga

Anthony Pompliano Says Open Naysayers Should Note New CEO Takes Home $1 Token Pay, Martin Shkreli Counters Company 'Fundamentally Broken'

iBuying platform Opendoor Technologies Inc. (NASDAQ:OPEN) has appointed Kaz Nejatian as its new CEO, who previously served as the COO of Shopify Inc. (NASDAQ:SHOP). His illustrious background and new shareholder-aligned compensation package are being hailed by analysts, investors and even critics alike.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Martin Shkreli Doubles Down On Opendoor 'Short' Call: 'Pharma-Bro' Draws Parallels With Newegg — 'Game Over Losers'

Former hedge fund manager and pharmaceutical executive, Martin Shkreli, doubled down on his bearish stance against Opendoor Technologies Inc. (NASDAQ:OPEN), drawing parallels with another retail favorite stock that has since witnessed a pullback.

Barchart

Martin Shkreli Is Fighting the Short Squeeze in Newegg Stock. How Should You Play NEGG Here?

The controversial former pharmaceutical executive has declared the stock to be a dud.

Benzinga

'Pharma Bro' CEO Jacked Price of A Life-Saving Drug From $13.50 to $750 Per Pill Overnight — And His Reason? 'We Needed to Turn a Profit'

Imagine needing a medication that costs less than a fast-food meal—only to wake up the next day and find it's suddenly priced like a luxury car payment…per single pill.

Benzinga

'Pharma Bro' Martin Shkreli Bets Against Soaring Newegg, But Stock Keeps Climbing

Newegg Commerce Inc. (NASDAQ:NEGG) shares skyrocketed over 22% in Wednesday’s session, extending a volatile run that has seen the stock swing dramatically this year. The surge came as the company expanded its stock sale program, addressed issues tied to a shareholder loan foreclosure, and added its chief executive to the…

Benzinga

'Pharma Bro' Martin Shkreli Shorts Newegg After 1,338% Rally, Calls It 'Close to Worthless'

Former hedge fund manager Martin Shkreli announced on Thursday that he has shorted Newegg Commerce Inc. (NASDAQ:NEGG) following the e-commerce retailer’s massive 1,338% surge this year, dismissing the company as fundamentally overvalued.

Barchart

Martin Shkreli Is Shorting This ‘Strong Buy’ Penny Stock. How Should You Play Shares Here?

Martin Shkreli says aTyr stock could crash as much as 80% within the next six weeks. ATYR shares are not particularly attractive even without his warning.

Benzinga

Palantir Touches New All-Time High Before Fading After Hours: What's Going On?

Shares of Palantir Technologies Inc. (NASDAQ:PLTR) surged to a fresh all-time high, despite there being no company-specific news to lead the session.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.